VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
COLL
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
COLLCollegium Pharmaceutical, Inc.
$35.98$1.2B
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksCOLLQuarterly Financials

Collegium Pharmaceutical, Inc. (COLL) Quarterly Financials

120+ quarters historyFree accessUpdated daily

Collegium Pharmaceutical, Inc. (COLL) quarterly income statement — complete revenue, gross profit & net income history

COLL Income Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricQ1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23Q3'23Q2'23Q1'23Q4'22Q3'22Q2'22Q1'22Q4'21Q3'21Q2'21
Sales/Revenue193.52M205.45M209.36M188M177.76M181.95M159.3M145.28M144.92M149.75M136.71M135.55M144.77M129.62M127.01M123.55M83.75M27.36M78.84M82.94M
Revenue Growth %8.87%12.92%31.42%29.41%22.66%21.51%16.53%7.18%0.11%15.53%7.63%9.71%72.85%373.72%61.1%48.96%-4.53%-64.13%-0.42%6.26%
Cost of Goods Sold76.27M77.07M80.19M79.62M80.43M83.66M62.51M54.47M53.47M55.12M56.4M61.72M67.36M79.83M68.17M71.19M35.26M28.7M32.73M32.7M
COGS % of Revenue39.41%37.51%38.3%42.35%45.25%45.98%39.24%37.49%36.89%36.81%41.25%45.53%46.53%61.59%53.67%57.62%42.09%104.87%41.51%39.43%
Gross Profit117.25M128.38M129.17M108.38M97.32M98.29M96.79M90.81M91.46M94.63M80.31M73.83M77.4M49.79M58.84M52.36M48.5M-1.33M46.11M50.24M
Gross Margin %60.59%62.49%61.7%57.65%54.75%54.02%60.76%62.51%63.11%63.19%58.75%54.47%53.47%38.41%46.33%42.38%57.9%-4.87%58.49%60.57%
Gross Profit Growth %20.47%30.61%33.45%19.36%6.42%3.87%20.52%23%18.16%90.06%36.49%40.99%59.6%3835.11%27.6%4.23%-12.77%-103.01%-4.32%3.88%
Operating Expenses85.28M69.15M65.55M73.28M75.64M60.18M61.95M43.34M41.98M32.94M35.3M38.19M52.77M38.03M38.37M41.25M58.51M32.79M31.96M33.83M
OpEx % of Revenue44.07%33.66%31.31%38.98%42.55%33.07%38.89%29.83%28.97%22%25.82%28.18%36.46%29.34%30.21%33.39%69.86%119.83%40.54%40.79%
Selling, General & Admin067.64M65.55M73.64M76.42M63.09M61.95M43.34M41.98M32.94M35.3M38.19M52.77M38.03M38.37M41.25M54.53M26.6M30.51M30.37M
SG&A % of Revenue-32.92%31.31%39.17%42.99%34.68%38.89%29.83%28.97%22%25.82%28.18%36.46%29.34%30.21%33.39%65.11%97.22%38.7%36.61%
Research & Development00000000000000003.98M1.61M1.45M3.46M
R&D % of Revenue----------------4.76%5.88%1.84%4.17%
Other Operating Expenses1000K1000K0-358K-786K-1000K000000000001000K00
Operating Income31.96M59.22M63.62M35.1M21.69M38.11M34.84M47.47M49.47M61.69M45.01M35.63M24.63M11.76M20.47M11.11M-10.02M-34.12M14.15M16.41M
Operating Margin %16.52%28.83%30.39%18.67%12.2%20.95%21.87%32.68%34.14%41.2%32.93%26.29%17.01%9.07%16.11%8.99%-11.96%-124.71%17.95%19.78%
Operating Income Growth %47.39%55.4%82.61%-26.05%-56.16%-38.22%-22.6%33.22%100.89%424.69%119.93%220.73%345.9%134.46%44.65%-32.29%-147.26%-327.54%-27.91%-0.85%
EBITDA87.9M228.96M120.13M91.71M78.25M94.62M76.59M82.94M84.91M97.15M82.12M73.88M62.8M54.86M58.42M49.54M9.62M-16.9M31.4M33.63M
EBITDA Margin %45.42%111.44%57.38%48.78%44.02%52.01%48.08%57.09%58.59%64.88%60.07%54.51%43.38%42.32%45.99%40.1%11.49%-61.78%39.82%40.55%
EBITDA Growth %12.33%141.97%56.85%10.58%-7.84%-2.6%-6.74%12.26%35.19%77.09%40.57%49.14%552.66%424.56%86.06%47.31%-74.96%-152.7%-14.25%0.27%
D&A (Non-Cash Add-back)55.94M169.74M56.51M56.61M56.56M56.51M41.75M35.47M35.43M35.46M37.11M38.25M38.18M43.1M37.95M38.43M19.64M17.22M17.25M17.22M
EBIT31.96M133.83M65.2M37.49M23.91M39.92M33.97M44.68M53.96M65.99M49.55M39.66M3.87M12.78M20.48M11.12M-10.01M-34.12M14.15M16.41M
Net Interest Income-12.16M-101.23M-18.65M-18.08M-18.57M-20.84M-15.11M-11.19M-12.85M-14.98M-16.23M-17.84M-18.68M-19.55M-19.04M-17.76M-5.83M-4.75M-5.11M-5.42M
Interest Income3.71M3.56M3.12M2.38M2.23M1.81M3.28M4.4M4.49M4.3M4.54M4.03M2.75M1.03M11K5K4K3K3K3K
Interest Expense15.86M104.79M21.77M20.46M20.79M22.65M18.39M15.59M17.34M19.28M20.77M21.86M21.43M20.57M19.05M17.76M5.83M4.76M5.12M5.42M
Other Income/Expense-13.22M-30.19M-20.18M-18.08M-18.57M-20.84M-19.26M-18.37M-12.85M-14.98M-16.23M-17.84M-42.18M-19.55M-19.04M-17.76M-5.83M-4.75M-5.11M-5.42M
Pretax Income18.74M29.04M43.44M17.02M3.12M17.27M15.58M29.1M36.62M46.71M28.78M17.8M-17.56M-7.79M1.43M-6.65M-15.84M-38.88M9.04M10.99M
Pretax Margin %9.68%14.13%20.75%9.06%1.76%9.49%9.78%20.03%25.27%31.19%21.05%13.13%-12.13%-6.01%1.13%-5.38%-18.92%-142.08%11.46%13.25%
Income Tax4.24M12.07M11.93M5.04M705K4.73M6.25M9.49M8.91M14.77M8.15M4.79M-131K-592K975K-1.46M-2.77M-13.84M991K-61.85M
Effective Tax Rate %22.65%41.58%27.46%29.62%22.58%27.41%40.08%32.62%24.33%31.62%28.31%26.91%0.75%7.6%68.09%21.89%17.5%35.61%10.97%-562.75%
Net Income14.5M16.96M31.51M11.98M2.42M12.54M9.34M19.61M27.71M31.94M20.63M13.01M-17.43M-7.2M457K-5.19M-13.07M-25.03M8.05M72.84M
Net Margin %7.49%8.26%15.05%6.37%1.36%6.89%5.86%13.5%19.12%21.33%15.09%9.6%-12.04%-5.55%0.36%-4.2%-15.6%-91.49%10.21%87.82%
Net Income Growth %499.75%35.31%237.51%-38.88%-91.28%-60.75%-54.76%50.73%259.03%543.67%4415.1%350.57%-33.34%71.24%-94.32%-107.13%-183.44%-459.79%-28.71%803.98%
Net Income (Continuing)14.5M16.96M31.51M11.98M2.42M12.54M9.34M19.61M27.71M31.94M20.63M13.01M-17.43M-7.2M457K-5.19M-13.07M-25.03M8.05M72.84M
Discontinued Operations00000000000000000000
Minority Interest00000000000000000000
EPS (Diluted)0.400.460.840.340.070.350.270.520.710.820.530.34-0.51-0.210.01-0.15-0.39-0.730.221.79
EPS Growth %443.48%31.43%211.11%-34.62%-89.63%-57.32%-49.06%52.94%239.22%490.48%3915.15%326.67%-30.77%71.23%-94%-108.38%-195.12%-465%-31.25%678.26%
EPS (Basic)0.450.541.000.380.080.390.330.600.860.990.610.38-0.51-0.210.01-0.15-0.39-0.730.232.06
Diluted Shares Outstanding40.07M39.7M39.44M39.08M32.84M40.11M40.16M40.38M41.44M41.28M42.06M42.85M34.32M33.58M34.57M34M33.67M34.12M36.26M41.29M
Basic Shares Outstanding32.09M31.71M31.57M31.81M31.79M32.08M32.26M32.43M32.33M32.3M33.74M34.62M34.32M33.58M34.06M34M33.51M34.11M35.37M35.3M
Dividend Payout Ratio--------------------